Akadeum Life Sciences

Executive Summary

Akadeum Life Sciences is a private biotechnology company headquartered in Ann Arbor, Michigan, pioneering a novel microbubble-based platform for gentle and efficient cell separation and isolation. Founded in 2015, the company's technology addresses critical challenges in the cell therapy and diagnostics sectors by improving cell quality, therapeutic outcomes, and reducing manufacturing costs. By enabling more precise and less damaging cell isolation, Akadeum aims to accelerate the development of next-generation cell therapies and enhance diagnostic accuracy. The platform's versatility positions it as a key enabler for both research and clinical applications, potentially disrupting traditional centrifugation and magnetic bead-based methods. With a strong focus on scalability and cost-effectiveness, Akadeum is strategically positioned to capture value in the rapidly growing cell therapy market, which demands higher yields and better viability of therapeutic cells.

Upcoming Catalysts (preview)

• H2 2026Series A or B Funding Round Announcement75% success
• Q4 2026Strategic Partnership with a Major Cell Therapy Developer60% success
• Q3 2026Commercial Launch of First Product for Research Use50% success